← EU FEED

MediWound Reports Fourth Quarter and Full Year 2025 Financial Results

AI BRIEFING

  • EscharEx Phase III VALUE trial on track, no financial results provided
  • No specific financial metrics mentioned
  • Company's fourth quarter and full year 2025 financial results will be disclosed in a separate press release
ADVERTISEMENT
READ ORIGINAL ARTICLE